Your trusted source for DEA compliance updates & industry insights
DEA Diversion News
- Former Senior DEA Official Warns Against Issuing Schedule III Marijuana Licenses Until Federal Appeals Court Rules - Newswire.com
Former Senior DEA Official Warns Against Issuing Schedule III Marijuana Licenses Until Federal Appeals Court Rules Newswire.com
- DEA denies MedPharm Research bulk marijuana manufacturer registration over diversion violations - MMJDaily
DEA denies MedPharm Research bulk marijuana manufacturer registration over diversion violations MMJDaily
- U.S. attorney reaches $4.17M civil settlement, compliance agreement with WVU Health System over controlled substance violations - The Dominion Post
U.S. attorney reaches $4.17M civil settlement, compliance agreement with WVU Health System over controlled substance violations The Dominion Post
- Medical Cannabis Operators Face June 26 DEA Registration Deadline - mg Magazine
Medical Cannabis Operators Face June 26 DEA Registration Deadline mg Magazine
- DEA Official Highlights Pharmacists’ Role in Preventing Drug Diversion at 2026 Paul Pumpian Memorial Lecture - The University of Maryland, Baltimore
DEA Official Highlights Pharmacists’ Role in Preventing Drug Diversion at 2026 Paul Pumpian Memorial Lecture The University of Maryland, Baltimore
- Ex-DEA agent receives diversion - Santa Clarita Valley Signal
Ex-DEA agent receives diversion Santa Clarita Valley Signal
- Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait? - Newswire.com
Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait? Newswire.com
- DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs - Cannabis Business Times
DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs Cannabis Business Times
- DEA Schedule III Registration Asks Cannabis Businesses to Admit to Drug Trafficking - Cannabis Business Times
DEA Schedule III Registration Asks Cannabis Businesses to Admit to Drug Trafficking Cannabis Business Times
- DEA details new rules for Oklahoma dispensaries after marijuana reclassification - The Oklahoman
DEA details new rules for Oklahoma dispensaries after marijuana reclassification The Oklahoman
- Pennsylvania Pain and Addiction Summit - Wilkes University
Pennsylvania Pain and Addiction Summit Wilkes University
- DEA suspends Chattanooga pharmacy Monday: Pharmacist accused of sexual misconduct - WTVC
DEA suspends Chattanooga pharmacy Monday: Pharmacist accused of sexual misconduct WTVC
Pharma Industry News
- Cephalosporin Drugs Market Forecast to 2035: Demand to Accelerate on Rising Hospital-Acquired Infections - IndexBox
Cephalosporin Drugs Market Forecast to 2035: Demand to Accelerate on Rising Hospital-Acquired Infections IndexBox
- Up and down the ladder: The latest comings and goings - STAT
Up and down the ladder: The latest comings and goings STAT
- Nephron Pharmaceuticals Announces Leadership Transition - Business Wire
Nephron Pharmaceuticals Announces Leadership Transition Business Wire
- Donald Trump raised stakes in drug companies gaining from medicare exemptions, say Democrats - The Economic Times
Donald Trump raised stakes in drug companies gaining from medicare exemptions, say Democrats The Economic Times
- Trump's pharma holdings surged as drugmakers benefited from Medicare price negotiation carveouts, Democrats allege - Fierce Pharma
Trump's pharma holdings surged as drugmakers benefited from Medicare price negotiation carveouts, Democrats allege Fierce Pharma
- Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions - Fierce Biotech
Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions Fierce Biotech
- OPINION | The ‘One Big Beautiful Bill’ opened the door to benefit Big Pharma — and Trump - MS NOW
OPINION | The ‘One Big Beautiful Bill’ opened the door to benefit Big Pharma — and Trump MS NOW
- Cell Therapies, S2N.Bio Commence Tech Transfer for Alzheimer’s Candidate - Contract Pharma
Cell Therapies, S2N.Bio Commence Tech Transfer for Alzheimer’s Candidate Contract Pharma
- Co-Emulsifiers Market To 2035: Demand Rises on Poorly Soluble Drug Pipeline - News and Statistics - IndexBox
Co-Emulsifiers Market To 2035: Demand Rises on Poorly Soluble Drug Pipeline - News and Statistics IndexBox
- Joha rice starch emerges as a powerful tablet excipient rivaling corn starch - Bioengineer.org
Joha rice starch emerges as a powerful tablet excipient rivaling corn starch Bioengineer.org
- Chicago industrial market dynamics, Q3 2026 - JLL
Chicago industrial market dynamics, Q3 2026 JLL
- Greater China Logistics Market Q2 2026 - Cushman & Wakefield
Greater China Logistics Market Q2 2026 Cushman & Wakefield